[go: up one dir, main page]

SG11201509201WA - Methods and compositions related to large scale production of proteins - Google Patents

Methods and compositions related to large scale production of proteins

Info

Publication number
SG11201509201WA
SG11201509201WA SG11201509201WA SG11201509201WA SG11201509201WA SG 11201509201W A SG11201509201W A SG 11201509201WA SG 11201509201W A SG11201509201W A SG 11201509201WA SG 11201509201W A SG11201509201W A SG 11201509201WA SG 11201509201W A SG11201509201W A SG 11201509201WA
Authority
SG
Singapore
Prior art keywords
proteins
methods
large scale
scale production
compositions related
Prior art date
Application number
SG11201509201WA
Inventor
James Kelly
Original Assignee
Cell Machines Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cell Machines Inc filed Critical Cell Machines Inc
Publication of SG11201509201WA publication Critical patent/SG11201509201WA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/644—Coagulation factor IXa (3.4.21.22)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/94—Stability, e.g. half-life, pH, temperature or enzyme-resistance
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/31—Fusion polypeptide fusions, other than Fc, for prolonged plasma life, e.g. albumin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/01—Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01008—Cholinesterase (3.1.1.8), i.e. butyrylcholine-esterase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21022—Coagulation factor IXa (3.4.21.22)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG11201509201WA 2013-05-06 2014-05-06 Methods and compositions related to large scale production of proteins SG11201509201WA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361819912P 2013-05-06 2013-05-06
US201461954692P 2014-03-18 2014-03-18
PCT/US2014/036947 WO2014182684A2 (en) 2013-05-06 2014-05-06 Methods and compositions related to large scale production of proteins

Publications (1)

Publication Number Publication Date
SG11201509201WA true SG11201509201WA (en) 2015-12-30

Family

ID=51867852

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201509201WA SG11201509201WA (en) 2013-05-06 2014-05-06 Methods and compositions related to large scale production of proteins

Country Status (4)

Country Link
US (1) US20160207978A1 (en)
EP (1) EP2994483A4 (en)
SG (1) SG11201509201WA (en)
WO (1) WO2014182684A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112015032695A2 (en) 2013-07-04 2017-10-24 Glykos Finland Oy o-mannosyltransferase-deficient filamentous fungal cells and methods of using them
CN108064266A (en) 2014-07-21 2018-05-22 格利科斯芬兰公司 The preparation of the glycoprotein with mammal sample N- glycan in filamentous fungi
GB201420139D0 (en) 2014-11-12 2014-12-24 Ucl Business Plc Factor IX gene therapy
AU2016315699B2 (en) * 2015-08-31 2021-09-09 The Trustees Of The University Of Pennsylvania AAV-EPO for treating companion animals
WO2019169245A1 (en) 2018-03-02 2019-09-06 Sigilon Therapeutics, Inc. Biocompatible hydrogel capsules and process for preparing same
IL312315A (en) 2018-04-04 2024-06-01 Sigilon Therapeutics Inc Implantable particles and related methods
GB201813528D0 (en) 2018-08-20 2018-10-03 Ucl Business Plc Factor IX encoding nucleotides
US10842885B2 (en) 2018-08-20 2020-11-24 Ucl Business Ltd Factor IX encoding nucleotides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2471363C (en) * 2001-12-21 2014-02-11 Human Genome Sciences, Inc. Albumin fusion proteins
WO2003066078A1 (en) * 2002-02-07 2003-08-14 Delta Biotechnology Limited Hiv inhibiting proteins
KR101542752B1 (en) * 2006-12-22 2015-08-10 체에스엘 베링 게엠베하 Modified coagulation factors with prolonged in vivo half-life
MX2012006462A (en) * 2009-12-08 2012-10-03 Teva Pharma Bche albumin fusions for the treatment of cocaine abuse.

Also Published As

Publication number Publication date
WO2014182684A2 (en) 2014-11-13
EP2994483A2 (en) 2016-03-16
WO2014182684A3 (en) 2015-06-25
US20160207978A1 (en) 2016-07-21
EP2994483A4 (en) 2017-02-08

Similar Documents

Publication Publication Date Title
IL285780A (en) Tmprss6 irna compositions and methods of use thereof
ZA201507006B (en) Compositions and methods of nucleic acid-targeting nucleic acids
GB2535360B (en) Methods of preparing polyhemiaminals and polyhexahydrotriazines
SG10201705926YA (en) Methods for improved production of rebaudioside d and rebaudioside m
EP2964748A4 (en) Compositions and methods for biological production of isoprene
IL239894A0 (en) Stabilized compositions comprising hyaluronic acid and methods of preparing same
SG11201509201WA (en) Methods and compositions related to large scale production of proteins
ZA201506836B (en) Composition of artificial hair and production method thereof
IL244084A0 (en) Novel derivatives of uncialamycin and methods of synthesis
PL3008200T3 (en) Production of biodiesel and products obtained therefrom
GB201320475D0 (en) Improvements in or relating to calibration of instruments
SG11201505955PA (en) Novel polymer compositions and methods of making and using same
IL244453A0 (en) Methods of determining response to therapy
EP2986144A4 (en) Improved meat slurry methods of production and compositions
SG11201505891VA (en) Catalyst compositions and methods of making and using same
EP2943575A4 (en) Enzyme production compositions and methods
EP2984935A4 (en) Protein composition and production process therefor
IL245770A0 (en) Novel wheel and methods of production
IL240734A0 (en) Methods and compositions for preparation of nucleic acids
EP3008213A4 (en) Detection of protein to protein interactions
ZA201508714B (en) Production of human pulmonary surfactant protein b in plants
IL241248A0 (en) Enhanced expression of picornavirus proteins
SG11201509450QA (en) Methods to produce particles comprising therapeutic proteins
PL3089576T3 (en) Methods and compositions for production of watermelon fruit
PL3079684T3 (en) Compositions and methods for the treatment of diseases related to the renin-angiotensin-system